ImmunoGen, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

310,789

Value ($000)

9,215

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	9,215	0.0%	310,789	12/31/2023
2023 Q3	11/13/2023	4,857	0.0%	306,020	9/30/2023
2023 Q2	8/11/2023	1,128	0.0%	293,790	6/30/2023
2023 Q1	5/15/2023	1,128	0.0%	293,790	3/31/2023
2022 Q4	2/14/2023	1,226	0.0%	247,079	12/31/2022
2022 Q3	11/14/2022	1,169	0.0%	244,602	9/30/2022
2022 Q2	8/12/2022	989	0.0%	219,768	6/30/2022
2022 Q1	5/16/2022	891	0.0%	187,126	3/31/2022
2021 Q4	2/14/2022	1,388	0.0%	187,126	12/31/2021
2021 Q3	11/15/2021	908	0.0%	160,133	9/30/2021
2021 Q2	8/16/2021	1,036	0.0%	157,281	6/30/2021
2021 Q1	5/14/2021	1,178	0.0%	145,395	3/31/2021
2020 Q4	3/1/2021	1,044	0.0%	161,846	12/31/2020
2020 Q3	11/13/2020	583	0.0%	161,846	9/30/2020
2020 Q2	8/14/2020	744	0.0%	161,846	6/30/2020
2020 Q1	5/15/2020	512	0.0%	150,235	3/31/2020
2019 Q4	2/14/2020	959	0.0%	187,796	12/31/2019
2014 Q1	5/23/2014	464	0.0%	31,097	3/31/2014
2013 Q4	1/31/2014	428	0.0%	29,197	12/31/2013